|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 257, Issue 4 847-R853, Copyright © 1989 by American Physiological Society
ARTICLES |
K. P. Conrad and K. A. Vernier
Department of Physiology, Dartmouth Medical School, Hanover, New Hampshire 03756.
We postulated that guanosine 3',5'-cyclic monophosphate (cGMP), a cellular mediator of vascular smooth muscle relaxation, might mediate maternal renal and cardiovascular hemodynamic adaptation to pregnancy. Because extracellular levels of cGMP most likely reflect intracellular production, we began our investigation of this hypothesis by measuring the plasma concentration, urinary excretion, and metabolic clearance rates of cGMP during pregnancy in rats. Plasma cGMP was significantly elevated during mid- and late pregnancy, whereas urinary excretion of cGMP was increased throughout pregnancy. The fractional excretion of cGMP by the kidneys was 0.90 +/- 0.15 in the nonpregnant condition. In contrast, plasma levels of adenosine 3',5'-cyclic monophosphate were unchanged during pregnancy, and its urinary excretion rose slightly, reaching significance only on gestational day 20. There was also a significant rise in urinary excretion of cGMP throughout pseudopregnancy. The metabolic clearance rate of cGMP measured in chronically instrumented rats before, during, and after pregnancy was not significantly altered during gestation. The elevated plasma level of cGMP during gestation in rats, in the face of an unchanged metabolic clearance, reflects augmented tissue(s) production of cGMP, although enhanced cellular efflux may contribute. Because cGMP is a second messenger for several vasodilatory hormones, our data are consistent with the hypothesis that vascular production of cGMP may increase during pregnancy and thereby contribute to maternal renal and cardiovascular vasodilation. (Most investigators have not observed increment of plasma atrial natriuretic peptide in rat gestation; therefore this hormone is an unlikely first messenger for the elevated extracellular levels of cGMP that we have observed. Finally, pseudopregnant rats also showed enhanced urinary excretion of cGMP, which suggests that the proliferative activity that accompanies fetoplacental maturation, as well as hormones elaborated by the fetoplacental unit, is not necessary for the rise in urinary excretion of cGMP observed during pregnancy.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
J. M. Orshal and R. A. Khalil Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1013 - R1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Murphy, J. N. Herrington, J. P. Granger, and R. A. Khalil Enhanced [Ca2+]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H393 - H403. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Khalil and J. P. Granger Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R29 - R45. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Giardina, G. M. Green, K. L. Cockrell, J. P. Granger, and R. A. Khalil TNF-alpha enhances contraction and inhibits endothelial NO-cGMP relaxation in systemic vessels of pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R130 - R143. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Davis, J. B. Giardina, G. M. Green, B. T. Alexander, J. P. Granger, and R. A. Khalil Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha -induced hypertension in pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R390 - R399. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao, W. J. Pearce, and L. Zhang Pregnancy enhances endothelium-dependent relaxation of ovine uterine artery: role of NO and intracellular Ca2+ Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H183 - H190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Cadnapaphornchai, M. Ohara, K. G. Morris Jr., M. Knotek, B. Rogachev, T. Ladtkow, E. P. Carter, and R. W. Schrier Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy Am J Physiol Renal Physiol, April 1, 2001; 280(4): F592 - F598. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Murphy, J. B. Fleming, K. L. Cockrell, J. P. Granger, and R. A. Khalil [Ca2+]i signaling in renal arterial smooth muscle cells of pregnant rat is enhanced during inhibition of NOS Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R87 - R99. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Nelson, O. S. Steinsland, Y. Wang, C. Yallampalli, Y.-L. Dong, and J. M. Sanchez Increased Nitric Oxide Synthase Activity and Expression in the Human Uterine Artery During Pregnancy Circ. Res., September 1, 2000; 87(5): 406 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Kanashiro, K. L. Cockrell, B. T. Alexander, J. P. Granger, and R. A. Khalil Pregnancy-associated reduction in vascular protein kinase C activity rebounds during inhibition of NO synthesis Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R295 - R303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Crews, J. N. Herrington, J. P. Granger, and R. A. Khalil Decreased Endothelium-Dependent Vascular Relaxation During Reduction of Uterine Perfusion Pressure in Pregnant Rat Hypertension, January 1, 2000; 35(1): 367 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Salas, J. F. Vuletin, A. Giacaman, P. Rosso, and C. P. Vio Long-Term Nitric Oxide Synthase Inhibition in Rat Pregnancy Reduces Renal Kallikrein Hypertension, October 1, 1999; 34(4): 865 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Kanashiro, B. T. Alexander, J. P. Granger, and R. A. Khalil Ca2+-Insensitive Vascular Protein Kinase C During Pregnancy and NOS Inhibition Hypertension, October 1, 1999; 34(4): 924 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Conrad, L. J. Kerchner, and M. D. Mosher Plasma and 24-h NOx and cGMP during normal pregnancy and preeclampsia in women on a reduced NOx diet Am J Physiol Renal Physiol, July 1, 1999; 277(1): F48 - F57. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Conrad, R. E. Gandley, T. Ogawa, S. Nakanishi, and L. A. Danielson Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats Am J Physiol Renal Physiol, May 1, 1999; 276(5): F767 - F776. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Khalil, J. K. Crews, J. Novak, S. Kassab, and J. P. Granger Enhanced Vascular Reactivity During Inhibition of Nitric Oxide Synthesis in Pregnant Rats Hypertension, May 1, 1998; 31(5): 1065 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.A. Danielson and K.P. Conrad Prostaglandins Maintain Renal Vasodilation and Hyperfiltration During Chronic Nitric Oxide Synthase Blockade in Conscious Pregnant Rats Circ. Res., December 1, 1996; 79(6): 1161 - 1166. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |